57 - Séance principale
Oncology and metabolism
3 juin 2021, 17:35 - 19:05, Stream 4: Video Invited, SST, SSCViscérale & ARS


Video: Sodium thiosulfate, a source of hydrogen sulfide, promotes angiogenesis via inhibition of endothelial cells respiration
D. Macabrey, J. Joniová, A. Longchamp, J.-M. Corpataux, G. Wagnieres, S. Deglise, F. Allagnat, Presenter: F. Allagnat (Lausanne)

Therapies to accelerate vascular repair are currently lacking. Pre-clinical studies suggest that hydrogen sulfide (H2S), an endogenous gasotransmitter, promotes angiogenesis. Here, we hypothesized that sodium thiosulfate (STS), a clinically relevant H2S donor substance, would stimulate angiogenesis and vascular repair.
Mouse subjected to hindlimb ischemia were treated systemically with NaHS or STS and leg perfusion was measured by laser Doppler imaging. The pro-angiogenic effect of NaHS or STS was further assessed using a subcutaneous matrigel plug assay and a chick chorioallantoic membrane angiogenesis assay. Migration and proliferation of primary human umbilical endothelial cells (HUVEC) exposed to the same H2S donors were measured using a wound healing assay and BrDU incorporation, respectively. HUVEC respiration and glycolysis were measure in a seahorse apparatus.
STS stimulated arteriogenesis and vascular repair following hindlimb ischemia as evidence by increased laser Doppler imaging and vascular density in the gastrocninemius mucle in wild type C57BL/6J mice. STS also promoted angiogenesis assessed by matrigel plug assay and in the chick chorioallantoic membrane assay. In vitro, both STS and NaHS inhibited mitochondrial respiration and promoted glycolysis in HUVECs, which stimulated cell proliferation and migration and angiogenesis.
STS, a clinically pertinent source of sulfur, promotes angiogenesis and revascularization in a model of hindlimb ischemia. STS probably acts through metabolic reprogramming of endothelial cells toward a more proliferative glycolytic state. These findings may hold broad clinical implications for patients suffering from vascular occlusive diseases.
Notre site sauvegarde des traceurs textes (cookies) sur votre appareil afin de vous garantir de meilleurs contenus et à des fins de collectes statistiques. Vous pouvez désactiver l'usage des cookies en changeant les paramètres de votre navigateur. En poursuivant votre navigation sur notre site sans changer vos paramètres de navigateur, vous nous accordez la permission de conserver des informations sur votre appareil.